SCHEMBL9005585

SCHEMBL9005585

CC(C)Cc1ccc(Oc2cccc(C(=O)O)c2)cc1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.64
NPC1 O15118 1/20 0.58
POLB P06746 1/20 0.58
CYP2C9 P11712 1/20 0.58
RAB9A P51151 1/20 0.58
KMO O15229 1/20 0.55
KDM4E B2RXH2 1/20 0.55
SRD5A2 P31213 1/20 0.51
ADRB3 P13945 2/20 0.49
LPAR1 Q92633 1/20 0.49
ALDH1A1 P00352 2/20 0.49
LMNA P02545 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
NR4A2 P43354 2/20 0.49
KMT2A Q03164 1/20 0.49
ADRB1 P08588 1/20 0.48
FFAR1 O14842 1/20 0.48
NR4A1 P22736 1/20 0.48
NR4A3 Q92570 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9368992 0.85 SRD5A2 (0.60) AKR1C3NPC1POLBCYP2C9RAB9A
SCHEMBL21234444 0.84 AKR1C3 (0.70) AKR1C3NPC1POLBCYP2C9RAB9A
SCHEMBL9374242 0.83 PPARA (0.56) AKR1C3CYP2C9SRD5A2ADRB3LMNA
SCHEMBL18713541 0.83 FFAR1 (0.49) KDM4EALDH1A1SMN1; SMN2KMT2AFFAR1
SCHEMBL1042631 0.83 AKR1C3 (0.92) AKR1C3NPC1POLBCYP2C9RAB9A
SCHEMBL30266789 0.83 AKR1C3 (0.92) AKR1C3NPC1POLBCYP2C9RAB9A
SCHEMBL6682568 0.82 AKR1C3 (0.52) AKR1C3NPC1POLBCYP2C9RAB9A
SCHEMBL9374246 0.82 KMT2A (0.59) NR4A2KMT2AFFAR1NR4A1NR4A3
SCHEMBL27888993 0.81 AKR1C3 (0.66) AKR1C3NPC1POLBCYP2C9RAB9A
SCHEMBL4320685 0.81 AKR1C3 (0.96) AKR1C3NPC1POLBCYP2C9RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0579223-B1 Carboxylic acid derivatives having 5 alpha-reductase inhibitory activity MITSUBISHI CHEM CORP (JP) 1996-10-09 EP disclosed
US-5385917-A Treating androgen dependent diseases MITSUBISHI KASEI CORPORATION (JP) 1995-01-31 US disclosed
EP-0579223-A1 Carboxylic acid derivatives having 5 alpha-reductase inhibitory activity Mitsubishi Chemical Corporation (JP) 1994-01-19 EP disclosed